M
Marcin Dada
Researcher at Hartford Hospital
Publications - 34
Citations - 7331
Marcin Dada is an academic researcher from Hartford Hospital. The author has contributed to research in topics: Percutaneous coronary intervention & Conventional PCI. The author has an hindex of 22, co-authored 34 publications receiving 6792 citations. Previous affiliations of Marcin Dada include University of Connecticut.
Papers
More filters
Journal ArticleDOI
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
William E. Boden,Koon K. Teo,Pamela M. Hartigan,David J. Maron,William J. Kostuk,Merril L. Knudtson,Marcin Dada,Paul Casperson,Crystal L. Harris,Bernard R. Chaitman,Leslee J. Shaw,Gilbert Gosselin,Shah Nawaz,Lawrence M. Title,Gerald T. Gau,Alvin Blaustein,David C. Booth,Eric R. Bates,John A. Spertus,Daniel S. Berman,William S. Weintraub +20 more
TL;DR: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy.
Journal ArticleDOI
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw,Daniel S. Berman,David J. Maron,G.B. John Mancini,Sean W. Hayes,Pamela M. Hartigan,William S. Weintraub,Robert A. O'Rourke,Marcin Dada,John A. Spertus,Bernard R. Chaitman,John D. Friedman,Piotr J. Slomka,Gary V. Heller,Guido Germano,Gilbert Gosselin,Peter B. Berger,William J. Kostuk,Ronald G. Schwartz,Merill L Knudtson,Emir Veledar,Eric R. Bates,Benjamin D. McCallister,Koon K. Teo,William E. Boden +24 more
TL;DR: In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone, and the findings suggest a treatment target of ≥5% ischemic myocardium reduction with O MT with or without coronary revascularization.
Journal ArticleDOI
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
Abstr Act,Steven P. Sedlis,Pamela M. Hartigan,Koon K. Teo,David J. Maron,John A. Spertus,William J. Kostuk,Bernard R. Chaitman,Daniel S. Berman,Jeffrey D. Lorin,Marcin Dada,William S. Weintraub,William E. Boden +12 more
TL;DR: During an extended-follow-up of up to 15 years, there did not find a difference in survival between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease.
Journal ArticleDOI
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
G.B. John Mancini,Pamela M. Hartigan,Leslee J. Shaw,Daniel S. Berman,Sean W. Hayes,Eric R. Bates,David J. Maron,Koon K. Teo,Steven P. Sedlis,Bernard R. Chaitman,William S. Weintraub,John A. Spertus,William J. Kostuk,Marcin Dada,David C. Booth,William E. Boden +15 more
TL;DR: In a cohort of patients treated with OMT, anatomic burden was a consistent predictor of death, MI, and NSTE-ACS, whereas ischemic burden was not, and neither determination identified a patient profile benefiting preferentially from an invasive therapeutic strategy.
Journal ArticleDOI
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention
Leslee J. Shaw,William S. Weintraub,David J. Maron,Pamela M. Hartigan,Rory Hachamovitch,James K. Min,Marcin Dada,G.B. John Mancini,Sean W. Hayes,Robert A. O'Rourke,John A. Spertus,William J. Kostuk,Gilbert Gosselin,Bernard R. Chaitman,Merill L Knudtson,John D. Friedman,Piotr J. Slomka,Guido Germano,Eric R. Bates,Koon K. Teo,William E. Boden,Daniel S. Berman +21 more
TL;DR: From the COURAGE trial post hoc substudy, the extent of site-defined ischemia did not predict adverse events and did not alter treatment effectiveness.